Acorah Software Products - Accounts Production 16.3.350 false true false 28 September 2023 30 September 2024 30 September 2024 15171234 Mr Derek Curtis Mrs Santina Curtis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15171234 2023-09-27 15171234 2024-09-30 15171234 2023-09-28 2024-09-30 15171234 frs-core:CurrentFinancialInstruments 2024-09-30 15171234 frs-core:ShareCapital 2024-09-30 15171234 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30 15171234 frs-bus:PrivateLimitedCompanyLtd 2023-09-28 2024-09-30 15171234 frs-bus:FilletedAccounts 2023-09-28 2024-09-30 15171234 frs-bus:SmallEntities 2023-09-28 2024-09-30 15171234 frs-bus:AuditExempt-NoAccountantsReport 2023-09-28 2024-09-30 15171234 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-28 2024-09-30 15171234 frs-core:CostValuation 2023-09-27 15171234 frs-core:AdditionsToInvestments 2024-09-30 15171234 frs-core:DisposalsRepaymentsInvestments 2024-09-30 15171234 frs-core:FurtherSpecificIncreaseDecreaseInInvestments1ComponentTotalChangeInInvestments 2024-09-30 15171234 frs-core:CostValuation 2024-09-30 15171234 frs-core:ProvisionsForImpairmentInvestments 2023-09-27 15171234 frs-core:ProvisionsForImpairmentInvestments 2024-09-30 15171234 frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-core:UnlistedNon-exchangeTraded 2023-09-27 15171234 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-09-27 15171234 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-core:DisposalsRepaymentsInvestments frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-core:FurtherSpecificIncreaseDecreaseInInvestments1ComponentTotalChangeInInvestments frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-09-27 15171234 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-09-30 15171234 frs-bus:Director1 2023-09-28 2024-09-30 15171234 frs-bus:Director2 2023-09-28 2024-09-30 15171234 frs-countries:EnglandWales 2023-09-28 2024-09-30
Registered number: 15171234
Intermedical UK Holdings Limited
Unaudited Financial Statements
For The Year Ended 30 September 2024
Unaudited Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 15171234
2024
Notes £ £
FIXED ASSETS
Investments 4 8,193,839
8,193,839
CURRENT ASSETS
Debtors 5 46,338
Cash at bank and in hand 394,802
441,140
Creditors: Amounts Falling Due Within One Year 6 (77,155 )
NET CURRENT ASSETS (LIABILITIES) 363,985
TOTAL ASSETS LESS CURRENT LIABILITIES 8,557,824
NET ASSETS 8,557,824
CAPITAL AND RESERVES
Called up share capital 7 200
Profit and Loss Account 8,557,624
SHAREHOLDERS' FUNDS 8,557,824
Page 1
Page 2
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Derek Curtis
Director
27th June 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Intermedical UK Holdings Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15171234 . The registered office is 2 Exeter House Beaufort Court, Sir Thomas Longley Road, Rochester, Kent, ME2 4FE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
Page 3
Page 4
4. Investments
Subsidiaries Unlisted Total
£ £ £
Cost
As at 28 September 2023 - - -
Additions 100 12,317,391 12,317,491
Disposals - (4,196,914 ) (4,196,914 )
Fair value adjustments - 73,262 73,262
As at 30 September 2024 100 8,193,739 8,193,839
Provision
As at 28 September 2023 - - -
As at 30 September 2024 - - -
Net Book Value
As at 30 September 2024 100 8,193,739 8,193,839
As at 28 September 2023 - - -
Fair values of unlisted investments were obtained from Cazenove investment report
5. Debtors
2024
£
Due within one year
Amounts owed by group undertakings 1,948
Other debtors 44,390
46,338
6. Creditors: Amounts Falling Due Within One Year
2024
£
Other creditors 13,919
Taxation and social security 63,236
77,155
7. Share Capital
2024
£
Allotted, Called up and fully paid 200
Page 4